Heyman Enerio Gattuso & Hirzel LLP

Delaware

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Cases356
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechComp. Arch. and SoftwareCommunications
Top Attorneys
Patrick J. CoyneNeal S. CohenPeter Kinsella
Elite Ratings
DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
A

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered
Case
Description
11/15/24
Pfizer Inc v. Sandoz Inc
1:24-CV-01244
 (
D. DE
)
STIPULATION TO EXTEND TIME for Sandoz to move, answer, or otherwise respond to the Complaint to January 13, 2025 - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 11/15/2024)
11/08/24
Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc
1:22-CV-01395
 (
D. DE
)
NOTICE OF SERVICE of Defendants MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, and MSN Life Sciences Private Limiteds Notice Pursuant to 35 U.S.C. § 282 filed by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc..(Weinblatt, Richard) (Entered: 11/08/2024)
11/08/24
Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc
1:22-CV-01395
 (
D. DE
)
MEMORANDUM ORDER: The Daubert Motions (D.I. 1555 , 1559 ) are DENIED without prejudice to any specific objections at trial. (See Memorandum Order for further details). Signed by Judge Richard G. Andrews on 11/8/2024. Associated Cases: 1:20-md-02930-RGA, 1:22-cv-01395-RGA (aas) (Entered: 11/08/2024)
11/08/24
Novartis Pharmaceuticals Corp v. MSN Pharmaceuticals Inc
1:22-CV-01395
 (
D. DE
)
REDACTED VERSION of [341] Letter, by MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc.. (Weinblatt, Richard) Modified on 11/8/2024 (nms). (Entered: 11/08/2024)
11/01/24
Harmony Biosciences LLC v. Lupin Ltd
1:23-CV-01286
 (
D. DE
)
PROPOSED CONSENT JUDGMENT as to Novugen Pharma Sdn. Bhd. and Novugen Pharma (USA) LLC by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 11/01/2024)
10/30/24
Astellas Pharma Inc v. Lupin Ltd
1:23-CV-00819
 (
D. DE
)
NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc.'s and Zydus Lifesciences Limited's Objections and Responses to Plaintiffs' Notice of Deposition of Defendant Zydus Under Federal Rule of Civil Procedure 30(b)(6) filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Stombaugh, Alexis) (Entered: 10/30/2024)
10/30/24
Astellas Pharma Inc v. Lupin Ltd
1:23-CV-00819
 (
D. DE
)
MEMORANDUM AND ORDER: The Parties Motions for Claim Construction (D.I. [110] and D.I. [111] ) are GRANTED. (See Order for further details.) Ordered by Judge Joseph F. Bataillon on 10/30/2024. (vfm) (Entered: 10/30/2024)
10/24/24
Sandoz Inc v. Boehringer Ingelheim Pharmaceuticals Inc
1:24-CV-01192
 (
D. DE
)
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sandoz AG, Other Affiliate Sandoz Group AG for Sandoz Inc. filed by Sandoz Inc.. (oam) (Entered: 10/24/2024)
10/24/24
Sandoz Inc v. Boehringer Ingelheim Pharmaceuticals Inc
1:24-CV-01192
 (
D. DE
)
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,907,756; 10,105,323. (oam) (Entered: 10/24/2024)
10/24/24
Sandoz Inc v. Boehringer Ingelheim Pharmaceuticals Inc
1:24-CV-01192
 (
D. DE
)
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/20/2022. Date of Expiration of Patent: 06/4/2029 & 06/07/2029. (oam) (Entered: 10/24/2024)